EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in Glioblastoma

Mylan Blomquist(Mayo Clinic in Arizona), Nhan L. Tran(Mayo Clinic in Arizona)
International Journal of Molecular Sciences
June 6, 2024
Cited by 6


Related Papers